Studies have shown that the aberrant Th17 cell response in AIH is associated with altered aryl hydrocarbon receptor (AHR) signaling, leading to reduced responsiveness of Th17 cells to AHR activation. The gene discussed is AHR; the disease is autoimmune hepatitis.